​

Talis Biomedical (TLIS) Revenue & Revenue Breakdown

OverviewFinancialsChart

Talis Biomedical Revenue Highlights

Latest Revenue (Y)

$412.00K

0

Main Segment (Y)

Grant

Main Geography (Y)

Product

Talis Biomedical Revenue by Period

Talis Biomedical Revenue by Year

DateRevenueChange
2023-12-31$412.00K-88.72%
2022-12-31$3.65M100.00%
2021-12-31--100.00%
2020-12-31$10.94M175.03%
2019-12-31$3.98M66.40%
2018-12-31$2.39M-

Talis Biomedical generated $412.00K in revenue during NA 2023, up -88.72% compared to the previous quarter, and up 17.24% compared to the same period a year ago.

Talis Biomedical Revenue by Quarter

DateRevenueChange
2024-06-30--100.00%
2024-03-31$73.00K-51.66%
2023-12-31$151.00K98.68%
2023-09-30$76.00K58.33%
2023-06-30$48.00K-64.96%
2023-03-31$137.00K28.04%
2022-12-31$107.00K-85.34%
2022-09-30$730.00K45.42%
2022-06-30$502.00K-78.30%
2022-03-31$2.31M-1061109.17%
2021-12-31$-218.00-200.00%
2021-09-30$218.00100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$10.94K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$1.51M-

Talis Biomedical generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Talis Biomedical Revenue Breakdown

Talis Biomedical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Product$412.00K$3.65M
Grant$1.72M$1.16M

Talis Biomedical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant (80.69%), and Product (19.31%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Product$73.00K$227.00K$48.00K$137.00K$107.00K$730.00K$502.00K$2.31M
Grant-$108.00K$533.00K$1.08M$150.00K$66.00K$70.00K$874.00K

Talis Biomedical's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).

Talis Biomedical Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22
Grant$1.16M
Product$3.65M

Talis Biomedical's latest annual revenue breakdown by geography, as of Dec 22: Product (75.89%), and Grant (24.11%).

Talis Biomedical Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BVSBioventus$512.35M$138.96M
SGHTSight Sciences$81.06M$20.16M
NPCENeuroPace$65.42M$21.06M
SSKNSTRATA Skin Sciences$33.36M$8.44M
HSCSHeart Test Laboratories$18.60M-
NUWENuwellis$8.86M$2.37M
TNONTenon Medical$2.93M$887.00K
TIVCTivic Health Systems$1.18M$126.00K
BJDXBluejay Diagnostics--
BBLGBone Biologics--

TLIS Revenue FAQ

What is Talis Biomedical’s yearly revenue?

Talis Biomedical's yearly revenue for 2023 was $412K, representing a decrease of -88.72% compared to 2022. The company's yearly revenue for 2022 was $3.65M, representing an increase of 100.00% compared to 2021. TLIS's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

What is Talis Biomedical’s quarterly revenue?

Talis Biomedical's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $73K, a -51.66% decrease from the previous quarter (Q4 2023), and a -46.72% decrease year-over-year (Q1 2023). TLIS's quarterly revenue for Q4 2023 was $151K, a 98.68% increase from the previous quarter (Q3 2023), and a 41.12% increase year-over-year (Q4 2022).

What is Talis Biomedical’s revenue growth rate?

Talis Biomedical's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -89.64%.

What are Talis Biomedical’s revenue streams?

Talis Biomedical's revenue streams in c 23 are Product, and Grant. Product generated $412K in revenue, accounting 19.31% of the company's total revenue, down -88.72% year-over-year. Grant generated $1.72M in revenue, accounting 80.69% of the company's total revenue, up 48.45% year-over-year.

What is Talis Biomedical’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Talis Biomedical was Grant. This segment made a revenue of $1.72M, representing 80.69% of the company's total revenue.